PEX13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.380000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.383600E-01
Normal-vs-Stage2
2.115200E-01
Normal-vs-Stage3
8.635800E-01
Normal-vs-Stage4
4.971600E-02
Stage1-vs-Stage2
2.987200E-01
Stage1-vs-Stage3
5.288600E-01
Stage1-vs-Stage4
3.924100E-02
Stage2-vs-Stage3
1.858440E-01
Stage2-vs-Stage4
1.350390E-01
Stage3-vs-Stage4
3.926500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.463200E-01
Normal-vs-AfricanAmerican
2.567800E-01
Normal-vs-Asian
2.886800E-01
Caucasian-vs-AfricanAmerican
9.416200E-01
Caucasian-vs-Asian
7.808000E-01
AfricanAmerican-vs-Asian
8.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.623600E-01
Normal-vs-Female
1.840240E-01
Male-vs-Female
2.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.380000E-01
Normal-vs-Age(41-60Yrs)
1.689350E-01
Normal-vs-Age(61-80Yrs)
2.629000E-01
Normal-vs-Age(81-100Yrs)
2.768600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.066000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.616800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.551800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.211730E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.418000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.766000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.679200E-01
Normal-vs-Daily Drinker
3.093400E-01
Normal-vs-Weekly Drinker
4.912200E-01
Normal-vs-Occasional Drinker
7.002400E-02
Normal-vs-Social Drinker
1.528590E-01
Non Drinker-vs-Daily Drinker
9.213800E-01
Non Drinker-vs-Weekly Drinker
5.325400E-01
Non Drinker-vs-Occasional Drinker
7.727800E-02
Non Drinker-vs-Social Drinker
9.541200E-01
Daily Drinker-vs-Weekly Drinker
6.167200E-01
Daily Drinker-vs-Occasional Drinker
8.760100E-02
Daily Drinker-vs-Social Drinker
8.851400E-01
Weekly Drinker-vs-Occasional Drinker
5.428400E-02
Weekly Drinker-vs-Social Drinker
5.152000E-01
Occasional Drinker-vs-Social Drinker
1.116830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.706000E-02
Normal-vs-Grade 2
2.805600E-02
Normal-vs-Grade 3
4.856500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.056600E-03
Grade 1-vs-Grade 3
3.838000E-04
Grade 1-vs-Grade 4
5.706000E-02
Grade 2-vs-Grade 3
3.360000E-01
Grade 2-vs-Grade 4
2.805600E-02
Grade 3-vs-Grade 4
4.856500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.853000E-01
Normal-vs-NonDiabetic
2.632400E-01
Diabetic-vs-NonDiabetic
5.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.415800E-02
Normal-vs-NoPancreatitis
2.917200E-01
Pancreatitis-vs-NoPancreatitis
3.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.618600E-01
Normal-vs-N1
2.104600E-01
N0-vs-N1
8.894300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.983500E-03
Normal-vs-TP53-NonMutant
4.485400E-01
TP53-Mutant-vs-TP53-NonMutant
5.787900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
